Elevance Health Inc (LTS:0HG8)
$ 372.93 3.0083 (0.82%) Market Cap: 86.49 Bil Enterprise Value: 105.88 Bil PE Ratio: 13.63 PB Ratio: 1.99 GF Score: 85/100

Elevance Health Inc at Credit Suisse Healthcare Conference Transcript

Nov 09, 2022 / 07:35PM GMT
Release Date Price: $527.38 (-1.13%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

(technical difficulty)

these things out, asking people to talk a little bit about the wins for the year and some of the challenges. And you guys are focused particularly on the commercial side. So I might ask you that, and Steve can chime in if he wants on something more broadly. But is that all right, Morgan?

Questions & Answers

Charles Morgan Kendrick
Elevance Health Inc. - Executive VP and President of Commercial & Specialty Business Division

That's perfectly fine. No, A.J., thank you for having us. It's a pleasure to be with everybody. And yes, this year, actually, it's -- we're finishing up '22, which we started out remarkably well from a growth perspective, notably on the upper end of our fee-based business, both in large group local business as well as our national markets.

We've also concluded the '23 cycle as it relates to the national business, and we certainly know that -- we've talked about it a bit. It's been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot